Replies to post #418 on ImmunoGen Inc (IMGN)

[skitahoe]

I believe the technical conferences at the end of the year will bring further news about IMGN853 in different combinations, that should increase anticipation of it's approval. Some other products may be discussed as well.

My target for IMGN is over $13, where it was at the end of 2015 when news of dropping the registrational Phase 2 and going with the full Phase 3 dropped the price dramatically for all of 2016. At $13 we're just back to where we were then, when in fact we'll be well ahead as approval will have a greatly expanded label over what the registrational trial would have had.

Gary